与抗生素相关的腹超出C. 困难:一个范围审查
Vijairam Selvaraj1, Mohd Amer Alsamman2
1Department of Medicine The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.
抗生素相关的腹 (AAD) 源于肠道微生物群的破坏. 本综述阐明了 Clostridioides difficile 和其他微生物在 AAD 病变发生过程中的作用.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗生素的使用经常导致腹疾病.
- 抗生素相关性腹 (AAD) 的发病包括肠道微生物群的改变,病原体的过度生长和药物毒性.
- 不到33%的AAD病例与*Clostridioides difficile* (CDI) 有关,这表明其他原因仍然不太清楚.
研究的目的:
- 系统地审查有关AAD的现有数据.
- 阐明CDI和非CDI AAD的致病机制.
- 为了提供对AAD病因学的全面了解.
主要方法:
- 对AAD的当前文献进行系统审查.
- 对微生物变化和机会性病原体扩散的数据进行分析.
- 包含详细介绍病原机制的图形.
主要成果:
- 已确立的 Clostridioides difficile* 感染 (CDI) 的致病性.
- 确定了其他可谓的ADD微生物原因的不清楚的作用和机制,包括*Clostridium perfringens*,*Staphylococcus aureus*,*Klebsiella oxytoca*和*Candida物种*.
- 突出了诊断和治疗非CDI AAD的重大差距.
结论:
- AAD是一种复杂的疾病,具有多种潜在的微生物触发因素,超出*C. difficile*.
- 需要进一步的研究来澄清非CDI AAD的发病原因.
- 对于大多数AAD病例,需要改进诊断和治疗策略.
更多相关视频
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
